These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 36857950)

  • 41. Changes in core beliefs over time predict symptoms and functioning in clinical high risk for psychosis.
    Patton HN; Cowan HR; Mittal VA
    Early Interv Psychiatry; 2022 Mar; 16(3):311-315. PubMed ID: 33938147
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Bullying in clinical high risk for psychosis participants from the NAPLS-3 cohort.
    Braun A; Liu L; Bearden CE; Cadenhead KS; Cornblatt BA; Keshavan M; Mathalon DH; McGlashan TH; Perkins DO; Seidman LJ; Stone W; Tsuang MT; Walker EF; Woods SW; Cannon TD; Addington J
    Soc Psychiatry Psychiatr Epidemiol; 2022 Jul; 57(7):1379-1388. PubMed ID: 35113189
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prospective study of cannabis use in adolescents at clinical high risk for psychosis: impact on conversion to psychosis and functional outcome.
    Auther AM; McLaughlin D; Carrión RE; Nagachandran P; Correll CU; Cornblatt BA
    Psychol Med; 2012 Dec; 42(12):2485-97. PubMed ID: 22716931
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Stress exposure and sensitivity in the clinical high-risk syndrome: initial findings from the North American Prodrome Longitudinal Study (NAPLS).
    Trotman HD; Holtzman CW; Walker EF; Addington JM; Bearden CE; Cadenhead KS; Cannon TD; Cornblatt BA; Heinssen RK; Mathalon DH; Tsuang MT; Perkins DO; Seidman LJ; Woods SW; McGlashan TH
    Schizophr Res; 2014 Dec; 160(1-3):104-9. PubMed ID: 25443665
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Association of Structural Magnetic Resonance Imaging Measures With Psychosis Onset in Individuals at Clinical High Risk for Developing Psychosis: An ENIGMA Working Group Mega-analysis.
    ; Jalbrzikowski M; Hayes RA; Wood SJ; Nordholm D; Zhou JH; Fusar-Poli P; Uhlhaas PJ; Takahashi T; Sugranyes G; Kwak YB; Mathalon DH; Katagiri N; Hooker CI; Smigielski L; Colibazzi T; Via E; Tang J; Koike S; Rasser PE; Michel C; Lebedeva I; Hegelstad WTV; de la Fuente-Sandoval C; Waltz JA; Mizrahi R; Corcoran CM; Resch F; Tamnes CK; Haas SS; Lemmers-Jansen ILJ; Agartz I; Allen P; Amminger GP; Andreassen OA; Atkinson K; Bachman P; Baeza I; Baldwin H; Bartholomeusz CF; Borgwardt S; Catalano S; Chee MWL; Chen X; Cho KIK; Cooper RE; Cropley VL; Dolz M; Ebdrup BH; Fortea A; Glenthøj LB; Glenthøj BY; de Haan L; Hamilton HK; Harris MA; Haut KM; He Y; Heekeren K; Heinz A; Hubl D; Hwang WJ; Kaess M; Kasai K; Kim M; Kindler J; Klaunig MJ; Koppel A; Kristensen TD; Kwon JS; Lawrie SM; Lee J; León-Ortiz P; Lin A; Loewy RL; Ma X; McGorry P; McGuire P; Mizuno M; Møller P; Moncada-Habib T; Muñoz-Samons D; Nelson B; Nemoto T; Nordentoft M; Omelchenko MA; Oppedal K; Ouyang L; Pantelis C; Pariente JC; Raghava JM; Reyes-Madrigal F; Roach BJ; Røssberg JI; Rössler W; Salisbury DF; Sasabayashi D; Schall U; Schiffman J; Schlagenhauf F; Schmidt A; Sørensen ME; Suzuki M; Theodoridou A; Tomyshev AS; Tor J; Værnes TG; Velakoulis D; Venegoni GD; Vinogradov S; Wenneberg C; Westlye LT; Yamasue H; Yuan L; Yung AR; van Amelsvoort TAMJ; Turner JA; van Erp TGM; Thompson PM; Hernaus D
    JAMA Psychiatry; 2021 Jul; 78(7):753-766. PubMed ID: 33950164
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Neuropsychology of the prodrome to psychosis in the NAPLS consortium: relationship to family history and conversion to psychosis.
    Seidman LJ; Giuliano AJ; Meyer EC; Addington J; Cadenhead KS; Cannon TD; McGlashan TH; Perkins DO; Tsuang MT; Walker EF; Woods SW; Bearden CE; Christensen BK; Hawkins K; Heaton R; Keefe RS; Heinssen R; Cornblatt BA;
    Arch Gen Psychiatry; 2010 Jun; 67(6):578-88. PubMed ID: 20530007
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Substance use in individuals at clinical high risk of psychosis.
    Buchy L; Cadenhead KS; Cannon TD; Cornblatt BA; McGlashan TH; Perkins DO; Seidman LJ; Tsuang MT; Walker EF; Woods SW; Heinssen R; Bearden CE; Mathalon D; Addington J
    Psychol Med; 2015 Aug; 45(11):2275-84. PubMed ID: 25727300
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical outcomes in individuals at clinical high risk of psychosis who do not transition to psychosis: a meta-analysis.
    Salazar de Pablo G; Soardo L; Cabras A; Pereira J; Kaur S; Besana F; Arienti V; Coronelli F; Shin JI; Solmi M; Petros N; Carvalho AF; McGuire P; Fusar-Poli P
    Epidemiol Psychiatr Sci; 2022 Jan; 31():e9. PubMed ID: 35042573
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Symptomatic and functional remission of subjects at clinical high risk for psychosis: a 2-year naturalistic observational study.
    Lee TY; Kim SN; Correll CU; Byun MS; Kim E; Jang JH; Kang DH; Yun JY; Kwon JS
    Schizophr Res; 2014 Jul; 156(2-3):266-71. PubMed ID: 24815568
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Persistent negative symptoms in youth at clinical high risk for psychosis: A longitudinal study.
    Devoe DJ; Lu L; Cannon TD; Cadenhead KS; Cornblatt BA; McGlashan TH; Perkins DO; Seidman LJ; Tsuang MT; Woods SW; Walker EF; Mathalon DH; Bearden CE; Addington J
    Schizophr Res; 2021 Jan; 227():28-37. PubMed ID: 32362460
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Predicting psychosis risk using a specific measure of cognitive control: a 12-month longitudinal study.
    Guo JY; Niendam TA; Auther AM; Carrión RE; Cornblatt BA; Ragland JD; Adelsheim S; Calkins R; Sale TG; Taylor SF; McFarlane WR; Carter CS
    Psychol Med; 2020 Oct; 50(13):2230-2239. PubMed ID: 31507256
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Early traumatic experiences, perceived discrimination and conversion to psychosis in those at clinical high risk for psychosis.
    Stowkowy J; Liu L; Cadenhead KS; Cannon TD; Cornblatt BA; McGlashan TH; Perkins DO; Seidman LJ; Tsuang MT; Walker EF; Woods SW; Bearden CE; Mathalon DH; Addington J
    Soc Psychiatry Psychiatr Epidemiol; 2016 Apr; 51(4):497-503. PubMed ID: 26851943
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Adolescents at clinical-high risk for psychosis: Circadian rhythm disturbances predict worsened prognosis at 1-year follow-up.
    Lunsford-Avery JR; Gonçalves BDSB; Brietzke E; Bressan RA; Gadelha A; Auerbach RP; Mittal VA
    Schizophr Res; 2017 Nov; 189():37-42. PubMed ID: 28169087
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Life Event Stress and Reduced Cortical Thickness in Youth at Clinical High Risk for Psychosis and Healthy Control Subjects.
    Aberizk K; Collins MA; Addington J; Bearden CE; Cadenhead KS; Cornblatt BA; Mathalon DH; McGlashan TH; Perkins DO; Tsuang MT; Woods SW; Cannon TD; Walker EF
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2022 Feb; 7(2):171-179. PubMed ID: 33930604
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mismatch Negativity in Response to Auditory Deviance and Risk for Future Psychosis in Youth at Clinical High Risk for Psychosis.
    Hamilton HK; Roach BJ; Bachman PM; Belger A; Carrión RE; Duncan E; Johannesen JK; Light GA; Niznikiewicz MA; Addington J; Bearden CE; Cadenhead KS; Cornblatt BA; McGlashan TH; Perkins DO; Tsuang MT; Walker EF; Woods SW; Cannon TD; Mathalon DH
    JAMA Psychiatry; 2022 Aug; 79(8):780-789. PubMed ID: 35675082
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Course of psychotic symptoms, depression and global functioning in persons at clinical high risk of psychosis: Results of a longitudinal observation study over three years focusing on both converters and non-converters.
    Hengartner MP; Heekeren K; Dvorsky D; Walitza S; Rössler W; Theodoridou A
    Schizophr Res; 2017 Nov; 189():19-26. PubMed ID: 28139360
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Duration of Untreated Prodromal Psychosis and Cognitive Impairments.
    Zhang T; Cui H; Wei Y; Tang X; Xu L; Hu Y; Tang Y; Liu H; Wang Z; Chen T; Li C; Wang J
    JAMA Netw Open; 2024 Jan; 7(1):e2353426. PubMed ID: 38277145
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Duration of the psychosis prodrome.
    Powers AR; Addington J; Perkins DO; Bearden CE; Cadenhead KS; Cannon TD; Cornblatt BA; Mathalon DH; Seidman LJ; Tsuang MT; Walker EF; McGlashan TH; Woods SW
    Schizophr Res; 2020 Feb; 216():443-449. PubMed ID: 31806523
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Association of Attenuated Niacin Response With Inflammatory Imbalance and Prediction of Conversion to Psychosis From Clinical High-risk Stage.
    Zhang T; Xiao X; Wu H; Zeng J; Ye J; Gao Y; Hu Y; Xu L; Wei Y; Tang X; Liu H; Chen T; Liu X; Li C; Zhou L; Wu X; Wang J
    J Clin Psychiatry; 2023 Jul; 84(5):. PubMed ID: 37471530
    [No Abstract]   [Full Text] [Related]  

  • 60. Differential expression of haptoglobin in individuals at clinical high risk of psychosis and its association with global functioning and clinical symptoms.
    Healy C; Byrne J; Raj Suasi S; Föcking M; Mongan D; Kodosaki E; Heurich M; Cagney G; Wynne K; Bearden CE; Woods SW; Cornblatt B; Mathalon D; Stone W; Cannon TD; Addington J; Cadenhead KS; Perkins D; Jeffries C; Cotter D
    Brain Behav Immun; 2024 Mar; 117():175-180. PubMed ID: 38219978
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.